Introduction to Cardiac Positron

Discover more insights into Cardiac Positron

Keywords frequently search together with Cardiac Positron

Narrow sentence examples with built-in keyword filters

coronary artery disease myocardial perfusion imaging emission tomography computed Explore More

Cardiac Positron sentence examples within coronary artery disease

coronary artery disease 10.1016/j.ahj.2021.03.012

BACKGROUND The literature reports no randomized trial in chronic coronary artery disease (CAD) of a comprehensive management strategy integrating intense lifestyle management, maximal medical treatment to specific goals and high precision quantitative cardiac positron emission tomography (PET) for identifying high mortality risk patients needing essential invasive procedures.

Full Text

coronary artery disease 10.1007/s12350-021-02776-7

Cardiac positron emission tomography (PET) with assessment of myocardial blood flow reserve (MBFR) has matured over several decades and is now widely recognized as a powerful tool for the diagnosis of obstructive coronary artery disease (CAD), for the assessment of prognosis in patients with known or suspected CAD, and for informing decisions for revascularization.

Full Text

More coronary artery disease sentences More Sentences

Cardiac Positron sentence examples within myocardial perfusion imaging

myocardial perfusion imaging 10.1007/s12350-021-02586-x

It is noteworthy to point out that a large body of evidence shows cardiac positron emission tomography (PET) to exhibit a higher diagnostic accuracy than conventional single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for detection of CAD in stable chest pain patients.

Full Text

myocardial perfusion imaging 10.1007/s12350-021-02640-8

Cardiac positron emission tomography myocardial perfusion imaging (PET MPI) has been proposed to be a better modality for avoiding false positives in patient with LBBB compared to SPECT.

Full Text

More myocardial perfusion imaging sentences More Sentences

Cardiac Positron sentence examples within emission tomography computed

emission tomography computed 10.1093/eurheartj/ehab724.2744

Between April 2018-March 2020, we enrolled patients with chest discomfort who were admitted to a chest pain observation unit and underwent 3D cardiac positron emission tomography/computed tomography (PET/CT).

Full Text

emission tomography computed 10.22541/AU.162726377.70463793/V1

10 This retrospective observational study included seventy-nine patients between 2011 and 2019 who had suspected cardiac sarcoidosis based on clinical presentation and findings on late gadolinium-enhancement cardiac magnetic resonance and/or cardiac positron emission tomography-computed tomography with N-13 NH3 perfusion imaging and F-18 fluorodeoxyglucose.

Full Text

More emission tomography computed sentences More Sentences

Learn more from Cardiac Positron

Stres Cardiac Positron Explore More

Cardiac Positron sentence examples within Stres Cardiac Positron

Stres Cardiac Positron 10.1161/JAHA.120.018555

Methods and Results Consecutive patients with SLE who underwent symptom‐prompted stress cardiac positron emission tomography‐computed tomography were included (n=42).

Full Text

Stres Cardiac Positron 10.1007/s12350-018-01580-0

Pharmacologic stress cardiac positron emission tomography (PET) is a highly advanced technique for myocardial perfusion imaging (MPI).

Full Text

More Stres Cardiac Positron sentences More Sentences

Cardiac Positron sentence examples within cardiac positron emission

cardiac positron emission 10.1007/s12350-021-02586-x

It is noteworthy to point out that a large body of evidence shows cardiac positron emission tomography (PET) to exhibit a higher diagnostic accuracy than conventional single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for detection of CAD in stable chest pain patients.

Full Text

cardiac positron emission 10.1007/s12350-021-02640-8

Cardiac positron emission tomography myocardial perfusion imaging (PET MPI) has been proposed to be a better modality for avoiding false positives in patient with LBBB compared to SPECT.

Full Text

More cardiac positron emission sentences More Sentences

More Cardiac Positron sentence examples

10.1016/J.JACCAS.2020.11.032

We report on a patient with left internal mammary artery (LIMA) side branch steal syndrome and refractory angina who underwent successful transcatheter LIMA side branch closure after cardiac positron emission tomography−computed tomography assessment.

Full Text

More Cardiac Positron sentence examples

10.1007/s12350-021-02805-5

Since its initial description in animals and humans roughly 40 years ago for myocardial imaging, cardiac positron emission tomography (PET) has matured into the reference standard since it uniquely fulfills all of these ideal features.

Full Text

More Cardiac Positron sentence examples

10.1007/s11886-021-01478-3

The purpose of this review is to demonstrate, via case illustrations, the benefits offered by cardiac positron-emission tomography (PET) stress testing with coronary flow capacity (CFC) in the evaluation and treatment of patients with left ventricular (LV) dysfunction and CAD.

Full Text

More Cardiac Positron sentence examples

10.1161/CIRCIMAGING.120.011327

Cardiac positron emission tomography found intense 18F-fluorodeoxyglucose uptake of the lesion in favor of an active infectious or inflammatory process (Figure [F and G]).

Full Text

More Cardiac Positron sentence examples

10.2147/IJGM.S321156

The comparison of the two groups was made by using biochemical parameters (NT-proBNP, Troponin I, NO) and imaging techniques (echocardiography, cardiovascular magnetic resonance (CMR) and cardiac positron emission tomography (PET)).

Full Text

More Cardiac Positron sentence examples

10.21037/CDT-20-724

Cardiac positron emission tomography (PET) is a useful adjunct to the diagnosis of device infections as well as inflammatory conditions including cardiac sarcoidosis.

Full Text

More Cardiac Positron sentence examples

10.1007/s11886-021-01606-z

This review outlines the role of cardiac positron emission tomography (PET) and cardiac magnetic resonance imaging (CMR) in the diagnosis and prognosis of CAV.

Full Text

More Cardiac Positron sentence examples

10.1093/ehjcr/ytab072

CS was unmasked after a cardiac positron emission tomography (PET).

Full Text

More Cardiac Positron sentence examples

10.1002/mp.13345

PURPOSE Cardiac positron emission tomography/magnetic resonance imaging (PET/MRI) acquisition presents novel clinical applications thanks to the combination of viability and metabolic imaging (PET) and functional and structural imaging (MRI).

Full Text

More Cardiac Positron sentence examples

10.1007/s12350-019-01679-y

Cardiac positron emission tomography (PET) imaging steadily continues to evolve into a pivotal imaging modality for the management of patients with cardiovascular diseases.

Full Text

More Cardiac Positron sentence examples

10.1093/ofid/ofz360.278

In recent years, cardiac positron emission tomography (PET) has been identified as a useful tool in detecting occult endocardial infections.

Full Text

More Cardiac Positron sentence examples

10.1002/mp.13419

Accurate correction for patient whole-body motion is still a largely unsolved problem in cardiac positron emission tomography (PET) imaging.

Full Text

More Cardiac Positron sentence examples

10.20996/1819-6446-2019-15-2-198-203

However, arrhythmia reproducibility during stress tests, positive drug tests with nitroglycerin and beta-blocker, results of cardiac positron emission tomography with fatty acids revealed the ischemic genesis of arrhythmias, which was indirectly confirmed by a positive antiarrhythmic effect of the therapy with a metabolic drug (treatment with a beta-blocker was impossible because there was a sinus block).

Full Text

More Cardiac Positron sentence examples

10.1002/mp.13815

PURPOSE Patient body motion during a cardiac Positron Emission Tomography (PET) scan can severely degrade image quality.

Full Text

Learn more from Cardiac Positron

Cardiac Positron Emission Explore More

Keywords related to Cardiac

Cardiac Physiology Cardiac Contractile Cardiac Arrhythmogenesis Cardiac Catheter Cardiac Enzymes Cardiac Microvascular Cardiac Contractility Cardiac Specific Deletion Cardiac Surgeons Cardiac Arrhythmia Cardiac Testing Cardiac Icu Cardiac Rehab Cardiac Fibroblast Cardiac Diffuse Cardiac Wall Cardiac Heart Cardiac Zone Cardiac Electronic Cardiac Arrhythmias Cardiac Radiotherapy Cardiac Lipoma Cardiac Pathophysiology Cardiac Anomaly Cardiac Critical Cardiac Index Cardiac Enzyme Cardiac Angiography Cardiac Outpatients Cardiac Patients Cardiac Valvular Cardiac Graft Cardiac Septal Cardiac Benefits Cardiac Telemetry Cardiac Invasion Cardiac Transmural Cardiac Adaptations Cardiac Bypass Cardiac Pacing Cardiac Screening Cardiac Valves Cardiac Gating Cardiac Diagnosis Cardiac Segmentation Cardiac Stroke Cardiac Assist Cardiac Measures Cardiac Autophagy Cardiac Action Explore More

Keywords related to Positron

Cardiac Positron

Encyclopedia

Aug 19, 2022

What is/are Cardiac Positron?

Cardiac Positron - We report on a patient with left internal mammary artery (LIMA) side branch steal syndrome and refractory angina who underwent successful transcatheter LIMA side branch closure after cardiac positron emission tomography−computed tomography assessment. ^[1] Since its initial description in animals and humans roughly 40 years ago for myocardial imaging, cardiac positron emission tomography (PET) has matured into the reference standard since it uniquely fulfills all of these ideal features. ^[2] The purpose of this review is to demonstrate, via case illustrations, the benefits offered by cardiac positron-emission tomography (PET) stress testing with coronary flow capacity (CFC) in the evaluation and treatment of patients with left ventricular (LV) dysfunction and CAD. ^[3] Cardiac positron emission tomography found intense 18F-fluorodeoxyglucose uptake of the lesion in favor of an active infectious or inflammatory process (Figure [F and G]). ^[4] The comparison of the two groups was made by using biochemical parameters (NT-proBNP, Troponin I, NO) and imaging techniques (echocardiography, cardiovascular magnetic resonance (CMR) and cardiac positron emission tomography (PET)). ^[5] Cardiac positron emission tomography (PET) is a useful adjunct to the diagnosis of device infections as well as inflammatory conditions including cardiac sarcoidosis. ^[6] This review outlines the role of cardiac positron emission tomography (PET) and cardiac magnetic resonance imaging (CMR) in the diagnosis and prognosis of CAV. ^[7] CS was unmasked after a cardiac positron emission tomography (PET). ^[8] PURPOSE Cardiac positron emission tomography/magnetic resonance imaging (PET/MRI) acquisition presents novel clinical applications thanks to the combination of viability and metabolic imaging (PET) and functional and structural imaging (MRI). ^[9] Cardiac positron emission tomography (PET) imaging steadily continues to evolve into a pivotal imaging modality for the management of patients with cardiovascular diseases. ^[10] In recent years, cardiac positron emission tomography (PET) has been identified as a useful tool in detecting occult endocardial infections. ^[11] Accurate correction for patient whole-body motion is still a largely unsolved problem in cardiac positron emission tomography (PET) imaging. ^[12] However, arrhythmia reproducibility during stress tests, positive drug tests with nitroglycerin and beta-blocker, results of cardiac positron emission tomography with fatty acids revealed the ischemic genesis of arrhythmias, which was indirectly confirmed by a positive antiarrhythmic effect of the therapy with a metabolic drug (treatment with a beta-blocker was impossible because there was a sinus block). ^[13] PURPOSE Patient body motion during a cardiac Positron Emission Tomography (PET) scan can severely degrade image quality. ^[14]

coronary artery disease

BACKGROUND The literature reports no randomized trial in chronic coronary artery disease (CAD) of a comprehensive management strategy integrating intense lifestyle management, maximal medical treatment to specific goals and high precision quantitative cardiac positron emission tomography (PET) for identifying high mortality risk patients needing essential invasive procedures. ^[1] Cardiac positron emission tomography (PET) with assessment of myocardial blood flow reserve (MBFR) has matured over several decades and is now widely recognized as a powerful tool for the diagnosis of obstructive coronary artery disease (CAD), for the assessment of prognosis in patients with known or suspected CAD, and for informing decisions for revascularization. ^[2] Methods Cardiac positron emission tomography (PET) images from 30 patients with coronary artery disease (CAD) were retrospectively reconstructed into 900, 360, 180, 90, and 45 s durations. ^[3] Introduction Myocardial flow reserve (MFR) measurement is predictive of major adverse cardiovascular (CV) events (MACE) and has been shown to improve diagnostic performances of coronary artery disease (CAD) in cardiac positron emission tomography. ^[4] We performed a meta-meta-analysis to evaluate the prognostic value of coronary flow reserve (CFR) assessed by cardiac positron emission tomography (PET) imaging in patients with suspected or known coronary artery disease (CAD). ^[5] Higher imaging quality makes cardiac positron emission tomography (PET) desirable for evaluation of suspected coronary artery disease (CAD). ^[6]

myocardial perfusion imaging

emission tomography computed

Between April 2018-March 2020, we enrolled patients with chest discomfort who were admitted to a chest pain observation unit and underwent 3D cardiac positron emission tomography/computed tomography (PET/CT). ^[1] 10 This retrospective observational study included seventy-nine patients between 2011 and 2019 who had suspected cardiac sarcoidosis based on clinical presentation and findings on late gadolinium-enhancement cardiac magnetic resonance and/or cardiac positron emission tomography-computed tomography with N-13 NH3 perfusion imaging and F-18 fluorodeoxyglucose. ^[2] The aim of this prospective study was to explore the feasibility of 18F-fluoromisonidazole (18F-FMISO) cardiac positron emission tomography/computed tomography (PET/CT) in the detection of cardiac hypoxia in patients of ischemic heart disease (IHD) and to compare the uptake pattern with that of 99mTc-MIBI and 18F-fluorodeoxyglucose (18F-FDG). ^[3]

Stres Cardiac Positron

Methods and Results Consecutive patients with SLE who underwent symptom‐prompted stress cardiac positron emission tomography‐computed tomography were included (n=42). ^[1] Pharmacologic stress cardiac positron emission tomography (PET) is a highly advanced technique for myocardial perfusion imaging (MPI). ^[2]

cardiac positron emission

It is noteworthy to point out that a large body of evidence shows cardiac positron emission tomography (PET) to exhibit a higher diagnostic accuracy than conventional single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for detection of CAD in stable chest pain patients. ^[1] Cardiac positron emission tomography myocardial perfusion imaging (PET MPI) has been proposed to be a better modality for avoiding false positives in patient with LBBB compared to SPECT. ^[2] We report on a patient with left internal mammary artery (LIMA) side branch steal syndrome and refractory angina who underwent successful transcatheter LIMA side branch closure after cardiac positron emission tomography−computed tomography assessment. ^[3] Since its initial description in animals and humans roughly 40 years ago for myocardial imaging, cardiac positron emission tomography (PET) has matured into the reference standard since it uniquely fulfills all of these ideal features. ^[4] 5%] who underwent clinically indicated cardiac positron emission tomography (PET) stress tests (nitrogen-13 labeled ammonia or rubidium-82). ^[5] Methods and Results Consecutive patients with SLE who underwent symptom‐prompted stress cardiac positron emission tomography‐computed tomography were included (n=42). ^[6] BACKGROUND The literature reports no randomized trial in chronic coronary artery disease (CAD) of a comprehensive management strategy integrating intense lifestyle management, maximal medical treatment to specific goals and high precision quantitative cardiac positron emission tomography (PET) for identifying high mortality risk patients needing essential invasive procedures. ^[7] Cardiac positron emission tomography (PET) with assessment of myocardial blood flow reserve (MBFR) has matured over several decades and is now widely recognized as a powerful tool for the diagnosis of obstructive coronary artery disease (CAD), for the assessment of prognosis in patients with known or suspected CAD, and for informing decisions for revascularization. ^[8] Cardiac positron emission tomography found intense 18F-fluorodeoxyglucose uptake of the lesion in favor of an active infectious or inflammatory process (Figure [F and G]). ^[9] The comparison of the two groups was made by using biochemical parameters (NT-proBNP, Troponin I, NO) and imaging techniques (echocardiography, cardiovascular magnetic resonance (CMR) and cardiac positron emission tomography (PET)). ^[10] Methods Cardiac positron emission tomography (PET) images from 30 patients with coronary artery disease (CAD) were retrospectively reconstructed into 900, 360, 180, 90, and 45 s durations. ^[11] Cardiac positron emission tomography (PET) is a useful adjunct to the diagnosis of device infections as well as inflammatory conditions including cardiac sarcoidosis. ^[12] Between April 2018-March 2020, we enrolled patients with chest discomfort who were admitted to a chest pain observation unit and underwent 3D cardiac positron emission tomography/computed tomography (PET/CT). ^[13] This review outlines the role of cardiac positron emission tomography (PET) and cardiac magnetic resonance imaging (CMR) in the diagnosis and prognosis of CAV. ^[14] Introduction Myocardial flow reserve (MFR) measurement is predictive of major adverse cardiovascular (CV) events (MACE) and has been shown to improve diagnostic performances of coronary artery disease (CAD) in cardiac positron emission tomography. ^[15] CS was unmasked after a cardiac positron emission tomography (PET). ^[16] 10 This retrospective observational study included seventy-nine patients between 2011 and 2019 who had suspected cardiac sarcoidosis based on clinical presentation and findings on late gadolinium-enhancement cardiac magnetic resonance and/or cardiac positron emission tomography-computed tomography with N-13 NH3 perfusion imaging and F-18 fluorodeoxyglucose. ^[17] Pharmacologic stress cardiac positron emission tomography (PET) is a highly advanced technique for myocardial perfusion imaging (MPI). ^[18] PURPOSE Cardiac positron emission tomography/magnetic resonance imaging (PET/MRI) acquisition presents novel clinical applications thanks to the combination of viability and metabolic imaging (PET) and functional and structural imaging (MRI). ^[19] Cardiac positron emission tomography (PET) imaging steadily continues to evolve into a pivotal imaging modality for the management of patients with cardiovascular diseases. ^[20] Purpose The aim of this study was to evaluate and quantify the effect of improved attenuation correction (AC) including bone segmentation and truncation correction on 18F-Fluordesoxyglucose cardiac positron emission tomography/magnetic resonance (PET/MR) imaging. ^[21] We performed a meta-meta-analysis to evaluate the prognostic value of coronary flow reserve (CFR) assessed by cardiac positron emission tomography (PET) imaging in patients with suspected or known coronary artery disease (CAD). ^[22] In recent years, cardiac positron emission tomography (PET) has been identified as a useful tool in detecting occult endocardial infections. ^[23] Approximately 1 month, 1 year, and 3 years after device implantation, patients underwent [15O]H2O cardiac positron emission tomography. ^[24] The aim of this prospective study was to explore the feasibility of 18F-fluoromisonidazole (18F-FMISO) cardiac positron emission tomography/computed tomography (PET/CT) in the detection of cardiac hypoxia in patients of ischemic heart disease (IHD) and to compare the uptake pattern with that of 99mTc-MIBI and 18F-fluorodeoxyglucose (18F-FDG). ^[25] We analyzed resting ECGs of 149 patients with ICM undergoing cardiac positron emission tomography (PET) with 13N-ammonia (NH3) and 18F-fluorodeoxyglucose (FDG) at our institution. ^[26] Accurate correction for patient whole-body motion is still a largely unsolved problem in cardiac positron emission tomography (PET) imaging. ^[27] However, arrhythmia reproducibility during stress tests, positive drug tests with nitroglycerin and beta-blocker, results of cardiac positron emission tomography with fatty acids revealed the ischemic genesis of arrhythmias, which was indirectly confirmed by a positive antiarrhythmic effect of the therapy with a metabolic drug (treatment with a beta-blocker was impossible because there was a sinus block). ^[28] Background Cardiac positron emission tomography (PET) is routinely utilized to diagnose cardiac sarcoidosis, but may be positive in other cardiac conditions that result in myocardial inflammation. ^[29] Higher imaging quality makes cardiac positron emission tomography (PET) desirable for evaluation of suspected coronary artery disease (CAD). ^[30] PURPOSE Patient body motion during a cardiac Positron Emission Tomography (PET) scan can severely degrade image quality. ^[31]